Ori Gutwerg - 23 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, GENERICS
Signature
/s/ Ori Gutwerg, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
23 Aug 2023
Net transactions value
-$970,851
Form type
4
Filing time
25 Aug 2023, 16:22:42 UTC
Previous filing
09 Mar 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $425,178 +13,502 +21% $31.49 76,476 23 Aug 2023 Direct
transaction ANIP Common Stock Sale $842,390 -13,502 -18% $62.39 62,974 23 Aug 2023 Direct F1
transaction ANIP Common Stock Sale $128,461 -2,059 -3.3% $62.39 60,915 23 Aug 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $425,178 -13,502 -50% $31.49 13,504 23 Aug 2023 Common Stock 13,502 $31.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive.
F3 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025.